Healio - The Infectious Diseases Society of America has backed the use of tocilizumab for COVID-19.In a change to its clinical guidelines, the IDSA now “suggests”...
Articles from: Healio
Healio - Three large professional thyroid organizations issued a joint statement calling for new trials of combination therapy to treat hypothyroidism, citing new clinical endpoints and...
-
ICYMI: “Our authors believed that there were sufficient anecdotal data from patients and sufficient new scientific data ... that the issue deserved to be reconsidered." @ThyroidJournal @AmThyroidAssn #Thyroid #EndoTwitter https://t.co/P4zj4vE1JC
Healio - Patients with age-related macular degeneration who are undergoing cataract surgery should be seen within 4 weeks after surgery and appropriately treated within 14 days...
-
Study investigates effects of cataract surgery on AMD #ophthalmology #cataracts #surgery #ESCRS2021 @ESCRSofficial https://t.co/wRlkfw3xu0
Healio - The FDA reviewed data on Johnson & Johnson’s one-shot COVID-19 vaccine and found no issues that would prevent its emergency use authorization, according to...
-
The @US_FDA reviewed data on the @JNJNews one-shot #COVID19 vaccine and found no issues that would prevent its emergency use authorization, according to a briefing document meant for the expert panel that will review the vaccine this week. https://t.co/WNStOcPbUe
Rapid-Onset Psychosis and Cholinergic Rebound After Abrupt Discontinuation of Clozapine
posted 2 days
Mashup Score: 3
Healio - Psychiatric Annals | Clozapine is an effective atypical antipsychotic that has superior results in treatment-resistant schizophrenia. It is unique in many ways and is...
-
Case Report from the February issue: "Rapid-Onset #Psychosis and Cholinergic Rebound After Abrupt Discontinuation of #Clozapine". https://t.co/vZGaaEGK2y #Schizophrenia #suicide @NuHealthSystem https://t.co/vZGaaEGK2y
NLA scientific statement further cements CAC scoring in primary prevention
posted 2 days
Mashup Score: 2
Healio - Cardiology Today | The first technique for coronary artery calcium scoring was published in 1990. Given the lack of data at the time on...
-
Our February issue includes a commentary on how the @nationallipid scientific statement on coronary calcium scoring could further integrate CAC scoring into clinical practice https://t.co/Ssa7UYJNGx #cardiotwitter @rblument1 @AndyGagel @Js08Paul @GarimaVSharmaMD @CiccaroneCenter
Healio - Ketosis, as achieved via ketogenic diet or supplements, may improve cardiometabolic health in patients with CVD, particularly HF, according to a review published in...
-
Ketosis, as achieved via ketogenic diet or supplements, may improve cardiometabolic health in patients with CVD, particularly #HeartFailure @ACCinTouch #Keto @univgroningen @EndocrineToday #CardioTwitter https://t.co/r4lIq2nEJQ
ACR, medical societies reach consensus on hydroxychloroquine retinopathy
posted 8 hours
Mashup Score: 2
Healio - With proper dosing — 5 mg/kg or less per day — the risk for retinal toxicity associated with hydroxychloroquine use is less than 2%...
-
#rheumatology has finally reached a consensus with #Ophthalmology on #Hydroxychloroquine retinopathy according to a new joint statement https://t.co/k3rW08VItO https://t.co/k3rW08VItO
Low physical activity level may confer risk for instant, short-term MI death
posted 2 days
Mashup Score: 2
Healio - Moderate to high physical activity levels were associated with lower risk for instant and 28-day death related to MI, according to results published in...
-
Moderate to high physical activity levels were associated with lower risk for instant and 28-day death related to MI @ESC_Journals @escardio #cardiotwitter @MichaelEmeryMD @CleClinicMD @ClevelandClinic #nutrition https://t.co/f4lSeBP8DU
Low physical activity level may confer risk for instant, short-term MI death
posted 19 hours
Mashup Score: 2
Healio - Moderate to high physical activity levels were associated with lower risk for instant and 28-day death related to MI, according to results published in...
-
Get moving! Low physical activity level may confer risk for instant, short-term MI death https://t.co/BVH3sJqy5W
The @IDSAInfo has backed the use of tocilizumab for #COVID19. https://t.co/vJSf0Qs3J4